Javier Sobrado
Gastroenterology · Miami, FLNPI 1689636391
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,480 of the $8,566 with a category attached, or 75.7%. 27 manufacturers reported payments, led by GI Supply, Inc. at 24.5% of the total. Reporting peaked in 2019 at $3,426 and has fallen 59.8% since, to $1,378 in 2022.
Across 362 payments — averaging $23.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GI Supply, Inc.$2K
- AbbVie$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- QOL Medical, LLC$626
- Takeda Pharmaceuticals U.S.A., Inc.$501
- Nestle Healthcare Nutrition Inc.$327
- plus $2K from 21 others
Across 187 payments — averaging $7786.45 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$831K
- Eli Lilly$204K
- Bristol Myers Squibb$128K
- Braintree Laboratories, Inc.$110K
- Pfizer$60K
- Janssen Research & Development, LLC$48K
- plus $74K from 5 others
What the payments were for
- Speaking & faculty fees$2,01324%
- Food & beverage$6,48076%
- Education$190%
- Gifts$531%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GI Supply, Inc. | 3 | $2,100 |
| AbbVie(2 entities) | 93 | $1,869 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 84 | $1,116 |
| QOL Medical, LLC | 44 | $626 |
| Takeda Pharmaceuticals U.S.A., Inc. | 29 | $501 |
| Nestle Healthcare Nutrition Inc. | 10 | $327 |
| Johnson & Johnson(2 entities) | 16 | $249 |
| Gilead | 13 | $248 |
| Intercept Pharmaceuticals, Inc. | 10 | $224 |
| Braintree Laboratories, Inc. | 12 | $176 |
| Ironwood Pharmaceuticals, Inc | 9 | $133 |
| Perspectum Diagnostics Ltd | 1 | $119 |
| Boston Scientific | 1 | $113 |
| Redhill Biopharma Inc. | 8 | $112 |
| Axonics, Inc. | 1 | $108 |
| Ferring Pharmaceuticals Inc. | 6 | $104 |
| Merck | 4 | $72 |
| Ardelyx, Inc. | 3 | $67 |
| Sanofi | 2 | $44 |
| UCB, Inc. | 2 | $43 |
| Janssen Scientific Affairs, LLC | 2 | $39 |
| Bristol Myers Squibb | 2 | $38 |
| Alfasigma USA, Inc. | 2 | $37 |
| Evoke Pharma, Inc. | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Endo Pharmaceuticals Inc. | 1 | $23 |
| Pfizer | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZENPEP$198
- LiverMultiScan$119
- HABIB ENDOHPB$113
- Axonics$108
How this compares
$8,566 in reported general payments places this provider in the 75th percentile of 1,388 gastroenterology providers in Florida.
Other gastroenterology in Miami
- Lukasz KwapiszMiami$1.2M
- Joanna LopezMiami$670K
- Jerry MartelMiami$511K
- Andres GelrudMiami$208K
- Maria HernandezMiami$197K
- George SanchezMiami$117K
- Jodie BarkinMiami$101K
- Javier ParraMiami$68K
- Samuel GidayOrlando$2M
- Jennifer Seminerio-DiehlOrlando$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.